Imunon, Inc. (IMNN)
NASDAQ: IMNN · Real-Time Price · USD
6.70
-0.14 (-2.05%)
Aug 13, 2025, 4:00 PM - Market closed
Imunon Employees
Imunon had 25 employees as of December 31, 2024. The number of employees decreased by 8 or -24.24% compared to the previous year.
Employees
25
Change (1Y)
-8
Growth (1Y)
-24.24%
Revenue / Employee
n/a
Profits / Employee
-$629,830
Market Cap
16.89M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
IMNN News
- 8 days ago - IMUNON Recaps Highlights from 2025 Second Quarter Financial Results Conference Call - GlobeNewsWire
- 8 days ago - Imunon, Inc. (IMNN) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 9 days ago - IMUNON Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 15 days ago - IMUNON Announces First Patient Dosed in Phase 3 OVATION 3 Study of IMNN-001 in Newly Diagnosed Advanced Ovarian Cancer - GlobeNewsWire
- 16 days ago - IMUNON to Hold Second Quarter 2025 Financial Results and Business Update Conference Call on Tuesday, August 5, 2025 - GlobeNewsWire
- 17 days ago - IMUNON Announces Stock Dividend Boosting Shareholder Value - GlobeNewsWire
- 22 days ago - IMUNON Announces Reverse Stock Split - GlobeNewsWire
- 4 weeks ago - IMUNON Granted Continued Listing Extension by Nasdaq to Complete Compliance Plan - GlobeNewsWire